A small study suggests Mavenclad’s effectiveness in MS may be linked to how regulatory T-cells respond to treatment.

Teva Canada and Novartis Canada are collaborating to ensure continued access to Mayzent for people with active SPMS in Canada ...

BTK inhibitors such as tolebrutinib or evobrutinib work about as well as Aubagio at preventing relapses in MS, a review of ...

A higher adherence to a Mediterranean diet is linked to a lower risk of developing MS, particularly in nonsmokers and people ...

Signs of multiple sclerosis may surface years before diagnosis, as patients use healthcare more often for early symptoms.

Difficulty walking with MS is not just about physical limitations, but also emotions, stigma, and how others respond, a ...

Researchers have found that new myelin-making cells are constantly being made in the brain and spinal cord, even in the ...

AB Science has secured a patent in Japan, valid through February 2041, covering the use of masitinib for progressive forms of MS.

Cognitive impairment is more common and severe in older adults with MS than in younger patients, but this is driven by ...

A brief, four-session stress management program helped ease symptoms of depression and anxiety and reduced stress in people ...

Columnist Ben Hofmeister likens the three battlefield ways to degrade an adversary's abilities to the disruptions caused by ...

Dissolvable film BNT23001 led to about 40% higher cladribine exposure than tablets in a preclinical pig study, BioNxt ...